secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001213900-24-041736
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq staff determination to delist Heart Test Laboratories; company plans appeal and 1-for-100 reverse split
--------------------------------------------------------------------------------

- Received Nasdaq staff determination to delist under Low Priced Stocks Rule (closing bid ≤$0.10 for 10 consecutive days).
- Company intends to appeal by May 16, 2024; hearing will stay delisting pending Panel decision.
- Board filed Certificate of Amendment for a 1-for-100 reverse stock split to regain compliance.
- Reverse split also adjusts warrants; exercise price changes to $425.00 per share.
- Shareholders approved split at Jan 2024 annual meeting; board selected 1-for-100 ratio on May 6, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390024041736/0001213900-24-041736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390024041736/ea0205776-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-041736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer